PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints Surrozen Inc SRZN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing ClinicalStage Spending No Revenue Reported HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline Pulsenmore PLSM Surges 12 as Share Price Tests Key Resistance Level Crown Holdings Inc CCK Shows Modest Gains as It Nears Key Technical Levels FG Merger II Corp FGMC Holds Steady at 1033 as Trading Range Remains Narrow Stantec Inc STN Pulls Back 1 as Support Levels Come Into Focus PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results